Stage IV Nonsmall-Cell Lung CancerJames R. Rigas
GUIDELINE QUESTION: In patients with metastatic, stage IV non-small-cell lung cancer (NSCLC) does chemotherapy improve survival and quality of life? OBJECTIVE: To make recommendations about the role of chemotherapy in the treatment of metastatic (stage IV) NSCLC. OUTCOMES: Survival and quality of...
From June 1991 to August 1994, 61 patients with stage III unresectable non-small-cell lung cancer ( NSCLC ; 16 cases of stage IIIA with N2 bulky disease an... GV Scagliotti,U Ricardi,L Crinó,... - 《Cancer Chemotherapy & Pharmacology》 被引量: 5发表: 1996年 A Phase I/II Radiation...
The patients with T1-4, N0-3, Msite0-1 and adeno- or squamous carcinoma of stage IV NSCLC had a longer OS with local thoracic surgery in combination with chemotherapy or chemoradiation. Introduction Surgery plays an important role in the treatment of non–small-cell lung cancer (NSCLC) in...
revisiting stage iiib and iv non-small cell lung cancer : analysis of the surveillance, epidemiology, and end results data author links open overlay panel william n. william jr md a , heather y. lin phd b , j. jack lee phd b , scott m. lippman md a , jack a. roth md c , ...
Worldwide, lung cancer is the most common cause of cancer-related deaths. Molecular targeted therapies and immunotherapies for non-small-cell lung cancer (NSCLC) have improved outcomes markedly over the past two decades. However, the vast majority of adv
What is non-small cell lung cancer?Non-small cell lung cancer (NSCLC) is the most common type of lung cancer.What are the subtypes of NSCLC?Squamous cell carcinoma is found in cells that line the airways of the lungs. It is usually found in the middle of the lung. Adenocarcinoma is ...
Clin Cancer Res. 2011;17(4):827–35. Article CAS PubMed Google Scholar Krebs MG, Hou JM, Sloane R, Lancashire L, Priest L, Nonaka D, et al. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J...
Rigas. JR. Docetaxel in stage III and IV non-small cell lung cancer. Eur J Cancer 1995 ; 31A (Suppl 4): S18–20.Rigas JR.Docetaxel in stage Ⅲ and IV non-small cell lung cancer[J].1995,31(zk).Rigas JR. Docetaxel in stage III and IV non-small cell lung cancer. Eur J Cancer...
Second-line treat-ment of stage Ⅲ/Ⅳ non-small-cell lung cancer (NSCLC) with pemetrexed in routine clinical practice:evaluation of performance status and health-related quality of life[J].BMC Cancer 2012,12.Schuette W, Tesch H, Büttner H, Krause T, Soldatenkova V, Stoffregen C. Second-...